uconn

Purchasing Goods or Services

In general, State ethics laws prohibit faculty affiliated companies from selling goods or services to the University unless the company is awarded a contract through a public competitive procurement process. A UConn employee holding an interest in a faculty affiliated company / external entity should contact UConn Procurement Services and Sponsored Programs Services if the company would like to sell goods or services to UConn. Procurement Services will work with the appropriate departments to determine whether the sale would comply with State ethics laws and, if applicable, purchasing laws and regulations. If public competitive procurement is required, the UConn employee should play no role in the process (such as writing specifications for the good or service) and should not discuss the process with any UConn employee involved.

In addition, some research sponsors require advance notice or disclosure prior to purchasing goods and services from a faculty affiliated company. Sponsored Program Services must be contacted if there is a request or intent to purchase equipment or services from a company in which a faculty member on the award has significant financial interests to determine if prior approval from the sponsor or other steps are required.

Purchase and Use of Goods and Services from a Faculty Affiliated Company

Faculty affiliated companies /external entities (“the Company”) must comply with all state ethics obligations if and when the Company transacts business with the University or State of Connecticut.  For University employees who have an interest with a faculty affiliated company/external entity, the following obligations are worthy of particular note:

  • An individual with an interest in the Company may not participate in any procurement or contracting in which the University may buy products or services made or provided by the Company.
  • Unless an exception is granted by the Vice President for Research or designee, an individual with an interest in the Company may not participate in any subawarding process in which the University may subaward funds to the Company.  For additional information about subawards to/from faculty affiliated companies, please see Subawards and Subcontracts page.
  • The Company may be barred from a transaction if a University employee with an affiliation with the Company is privy to information that is not available to other companies and that would provide the Company with a competitive advantage over other companies.
  • The Company is generally only permitted to sell goods or services to the University or the State through an open and public process. For example, the Company is generally not permitted to sell “sole source” goods or services to the University or the State. The Office of University Compliance must be contacted prior to any such sale to determine whether the sale would comply with state law.

Obtaining and Moving Materials to/from a Faculty Affiliated Company

  • If a University employee obtains materials from the Company for their University research, Sponsored Program Services should be contacted for consideration of whether a Materials Transfer Agreement (MTA) is necessary.
  • If a University employee plans to move materials from their University laboratory to the Company, Technology Transfer and Venture Development should be contacted for an MTA.

Use of University Resources

Requests from faculty affiliated companies for access to and/or use of research lab space or equipment are reviewed to ensure research space and equipment remains committed to the research mission of the University. No one with a personal interest (or their subordinate) in the faculty affiliated company may authorize the use of University facilities and resources on behalf of UConn. For assistance, contact the Associate Vice President for Research Integrity & Regulatory Affairs or the Assistant Vice President for Research Finance in the OVPR.

 

Policies and Regulations

State of Connecticut Ethics Laws

University Guide to the State Code of Ethics

All University faculty and staff are subject to the Connecticut state ethics laws.  Connecticut State ethics laws are designed to prevent a state employee, his/her family, and any associated business(es) from benefiting personally from his/her position as a state employee. The guidance on Consulting Approval, Purchasing Goods or Services, Employment of Students, and Use of University Facilities/Resources, are intended to help the University community comply with state ethics laws and University policy.  While the University has developed its own policy based upon state ethics laws, the University Guide to the State Code of Ethics, the final authority to interpret and enforce these laws rests with the Office of State Ethics, an independent regulatory division of the state.

This policy includes several considerations related to conflicts of interest.

For guidance regarding individual situations, contact the Ethics Liaison.

University Policies

The following University policies are of particular importance for members of the University community who hold a financial interest in, or conduct University activities with, a faculty affiliated company.  Additional guidelines on these topics are available within this site.

Code of Conduct

The Code of Conduct includes campus-wide standards on conflict of interest.

For guidance regarding individual situations, contact the Office of University Compliance.

Faculty Consulting Policy

This policy addresses when a faculty member is working for a faculty affiliated company in a paid or unpaid capacity, including as an employee, consultant, or advisor.

For guidance regarding individual situations, contact the Faculty Consulting Office.

Use of Students in Outside Employment

This policy addresses if a student is to be employed by a faculty affiliated company / external entity.

Financial Conflict of Interest in Research (UConn Storrs/Regionals)

Individuals at UConn Storrs, School of Law, School of Social Work, and the Regional campuses who are involved in University research as an Investigator must make full and timely disclosures of financial interests, including any financial interests with a faculty affiliated company /external entity, according to this policy.

Consulting Disclosure and Approval

If a faculty member, or any other University personnel subject to the consulting policy, do any work for a faculty affiliated company, whether or not compensation is received, prior consulting approval from the University is required.  This approval is required even if the faculty affiliated company is not currently paying the faculty member.

For faculty members who have an ownership interest in a start-up company, that ownership must be disclosed when seeking consulting approval.

Faculty members must get consulting approval from the Department Head, Dean, and Provost if working for a faculty affiliated company in a paid or unpaid capacity.

Faculty must seek approval for  the Use of University Resources , including University equipment, while consulting.  Faculty members must reimburse the University for using University resources beyond di minimus amounts.

UCPEA staff should adhere to the provisions in Article 39 of the Collective Bargaining Agreement.

Approval under the University’s Faculty Consulting system is in addition to any other disclosure statements (e.g., for research financial disclosures).

Any consulting activity that is ongoing requires a new request form every fiscal year.

For questions related to the faculty consulting policy, contact the campus Faculty Consulting Office.

Disclosure of Financial Interests

Disclosure in Publications, Presentations, and Transactions

Individuals must disclose ownership and consulting relationships, if any, with a faculty affiliated company/external entity in all publications, presentations, and transactions related to the  company’s technology.  Likewise, the faculty affiliated company would disclose its relationship with the faculty member, and the individual’s role with the company, in all publications, presentations, and transactions related to the individual’s work in the development and marketing of its technology.

When an individual files an application for any grant or contract, whether through the University or through a faculty affiliated company/external entity, the individual must disclose their financial interest with the company as required by the granting or contracting entity.

For Investigators who own equity in a faculty affiliated company or start-up company, the ownership must also be disclosed through the University’s financial interest filing process described below.

Financial Conflict of Interest in Research  – Disclosure and Management

Individuals at the University involved in research must make full and timely disclosures to the Financial Conflict of Interest in Research Committee of all financial interests meeting the disclosure threshold for Significant Financial Interests (SFIs) within the InfoEd External Interests system.

This includes disclosure of any and all equity or other ownership interests in non publicly-traded entities, such as faculty affiliated companies or other non-public external entities, even if the company has no current value or the value is unknown.

These disclosures are reviewed and, where required, managed, reduced, or eliminated to address potential conflicts in the design, conduct, or reporting of research according to the University’s Financial Conflict of Interest in Research policy.  In some instances, there may be specific sponsor policies or requirements that are more restrictive than State ethics laws and UConn policy, and such applicable portions of sponsor policies or requirements will take precedence, while other aspects of State or University policy will remain in force.

Investigators should review the terms of all awards and must comply with all terms and conditions to be certain there are no additional restrictions pertaining to a company relationship.

Obligation to Update and Provide Information

If there is a change in an individual’s status or responsibilities related to a faculty affiliated company/external entity, the financial disclosure may be required to be updated and other University areas may also need to be notified (e.g., Faculty Consulting Office).  According to University policy, the research financial disclosure is required to be updated within thirty (30) days of the acquisition or discovery of any new significant financial interests.

Subawards and Subcontracts

Subaward from Faculty Affiliated Company to UConn

The University may accept research subcontracts/subawards from faculty affiliated companies (FAC) in which the FAC is the sponsor. All of the relevant requirements and policies for subcontracting to the University apply regardless of the fact that the subcontracting entity is a FAC. The University Conflict of Interest Committee(s) may place specific requirements on the investigator or others working on the project to manage, reduce or eliminate the conflict.

Subaward from UConn to a Faculty Affiliated Company

If the Principal Investigator (PI) is a faculty member who has an interest in a FAC, the University will not subcontract or issue a subaward to any FAC in which the PI has an interest.

If a Co-PI on the grant has an interest in a FAC, specific rules apply if there is a subcontract or a subaward to any FAC in which the Co-PI has an interest. As a state employee, a Co-PI may be prohibited by state ethics law from having the FAC contract with the University. There is an exception that allows a subcontract or subaward if it is intended to support a collaboration to develop and commercialize an invention or discovery. Many subcontracts and subawards may come within this exception. They are permitted, provided that the following additional requirements are also met:

  1. the PI does not have an ownership or other interest in the FAC receiving the subcontract or subaward
  2. the PI does not receive any financial gain from making the award
  3. the PI has made an independent decision based on the merits to select the FAC and the decision is not based on other factors such as personal or professional relations with the Co-PI
  4. the Co-PI did not participate in the decision to make the award to the FAC
  5. the FAC receiving the subaward or subcontract must be qualified to do the work, and the economic and other terms must be commercially reasonable; and
  6. the evaluation of the work product and the approval of invoices from the company must be done by the PI independently, without the participation of the Co-PI. In addition, in these situations, UConn will inform the sponsor of the potential conflict and confirm that the sponsor has no objections.

The PI cannot receive a payment from the Co-PI or the company receiving the subaward or subcontract. Nor can there be any agreement to funnel subawards or subcontracts to a company in which the PI has an interest.

As noted elsewhere, this does not address any restrictions that may be imposed by the funding source, whether a federal grant or otherwise. The application of those rules needs to be evaluated in the context of the specific situation.

For assistance , contact Mark Reeves, Director, Sponsored Program Contract Services, at mark.reeves@uconn.edu.

InfoEd and ORCID iD Integration

ORCID Display Badge 2019

ORCID Authenticate Badge 2019The InfoEd eRA Portal is integrated with ORCID®. ORCID iDs are unique identifiers assigned to individual scholars and researchers. ORCID provides a persistent identifier – an ORCID iD – that distinguishes you from other researchers and a mechanism for linking your research outputs and activities to your iD. Using an ORCID allows your manuscripts, grants, and other scholarship to be more discoverable and integrated within larger research networks. Faculty, staff and students at the University of Connecticut ORCiD can authenticate and display their ORCID iD along side their name on their InfoEd Genius profile. The InfoEd-ORCID was the first ORCID iD integration at the University of Connecticut and was completed in August, 2019. In November, 2019 InfoEd UConn Health and ORCID integration went live.

Connect

From your InfoEd profile, click the “Connect Your ORCiD ID” link to begin the Authentication process. If you already have an ORCID, enter your Email or ORCID iD and ORCID password, and then click sign into ORCID button to login with your ORCID account. You may sign in through a personal or Instititonal account using your UConn NetID.  If you do not have an ORCID, click Register now to create one, provide the necessary information, and submit the registration form.

Authenticate

When you click the “Authorize” button, we ask you to share your iD using an authenticated process: either by registering for an ORCID iD or, if you already have one, to sign into your ORCID account. We do this to ensure you are correctly identified in our electronic Research Administration systems and are securely connecting your own unique ORCID iD.

Display

To acknowledge that you have used your iD and that it has been authenticated, we display the ORCID iD icon ORCiD alongside your name in your InfoEd Genius profile and provide a link to your ORCiD profile from within the InfoEd eRA Portal.

Contact

If you need help with connecting your ORCID iD to your InfoEd profile, email era-support@uconn.edu or call 860-486-7944.

If you have questions about getting an ORCID, how it will be used by the University of Connecticut, or any other related questions, please contact Carolyn.Mills@uconn.edu at UConn Libraries.

ORCID Consortium Organization Member

Important Information from the NIH and NSF

Dear Investigator,

On July 10th, the National Institutes of Health (NIH) published a reminder on NIH Policies on Other Support and on Policies related to Financial Conflicts of Interest and Foreign Components.  This was followed on July 11th by a Dear Colleague Letter on protecting research funded by the National Science Foundation (NSF) from NSF Director, Dr. France Córdova. These notices relate to the ongoing concerns regarding foreign influence in federally funded research.

In response to these publications, the OVPR recommends that any collaborations with foreign entities or individuals, or appointments with foreign entities (including foreign talent or similar programs) be disclosed to the NIH or NSF program officer, your Dean, and the OVPR (contacts and additional information listed below).

The OVPR has posted additional guidance on our site regarding Active and Pending Support and Foreign Collaborations. For any questions or for guidance on this and other related matters, please contact:

Thank you for your cooperation,

Radenka Maric, PhD
Vice President for Research
UConn/UConn Health

 

 

Important Information from the NIH and NSF for UConn/UConn Health Investigators

The NSF Letter references the draft NSF Proposal and Award Policies & Procedures Guide published in May 2019.  Clarifications in the draft Guide related to current and pending support and biographical sketches include:

  • Providing information for all current and pending support irrespective of whether such support is provided through the proposing organization or directly to the individual.
  • Expanding examples of current and pending support to include non-profit organizations and consulting agreements.
  • Reporting all projects and activities requiring a time commitment (no minimum has been established), even if the support received is only in-kind.
  • Appointments should include any titled academic, professional, or institutional position whether or not remuneration is received.

The Dear Colleague Letter also states the NSF will be issuing a policy that NSF personnel and Intergovernmental Personnel Act (IPA) assigned personnel cannot participate in foreign government talent-recruitment programs.

The NIH Notice reminds applicants that in regards to Other Support, they must:

  • List all positions and scientific appointments, both domestic and foreign, held by senior/key personnel which are relevant to an application including affiliations with foreign entities or governments such as titled academic, professional, or institutional appointments whether or not remuneration is received, and whether full-time, part-time, or voluntary (including adjunct, visiting, or honorary).
  • Report all resources and other support for all individuals designated in an application as senior/key personnel – including the program director/principal investigator and other individuals who contribute to the scientific development or execution of a project in a substantive, measurable way, whether or not they request salaries or compensation. All current support for ongoing projects must be included, irrespective of whether such support is provided through the applicant organization, through another domestic or foreign organization, or is provided directly to an individual who supports the senior/key personnel’s research efforts.
  • Report all current projects and activities involving senior/key personnel, even if the support received is only in-kind (e.g. office/laboratory space, equipment, supplies, employees), including, but not limited to, foreign financial support, research or laboratory personnel, lab space, scientific materials, selection to a foreign “talents” or similar-type program, or other foreign or domestic support.
  • Provide the total award amount for the entire award period covered (including facilities and administrative costs), as well as the number of person-months (or partial person-months) per year to be devoted to the project by the senior/key personnel.

 

The Notice also reminds applicants of the need to determine whether projects include a foreign component, defined as the existence of any “significant scientific element or segment of a project” outside of the United States including:

  • Performance of work by a researcher or recipient in a foreign location, whether or not NIH grant funds are expended and/or
  • Performance of work by a researcher in a foreign location employed or paid for by a foreign organization, whether or not NIH grant funds are expended.

 

If a significant portion of a project will be conducted outside the United States, then there is a foreign component and NIH prior approval is required.  If all project activity is conducted within the United States, but there is a non-U.S. resource supporting the project, it must be reported as other support.

Program in Accelerated Therapeutics for Healthcare (PATH) Awards

Dear Colleagues,

I’m very pleased to announce that the Office of the Vice President for Research (OVPR) has recently finalized award decisions for the inaugural cycle of the Program in Accelerated Therapeutics for Healthcare (PATH).  PATH is a partnership that includes the OVPR, the School of Pharmacy, and the School of Medicine to accelerate the translational pathway for researchers to convert their discoveries to new medical therapeutics. Under PATH, funding is provided to academic research programs designed to quickly develop novel therapeutic approaches focusing on well validated molecular targets for a specific disease area with an unmet treatment need in the current commercial marketplace. Projects focusing on a wide range of therapeutic interventions (small molecule, biologic, antibody, peptide, gene therapy) are eligible for consideration.

Given your leadership role in the University, I want you to be among the first to hear the results of this competition so you can join me in congratulating the awardees.  Seven PATH grants were awarded in two categories after a highly selective competition:

 

PATH Trailblazer Grants – $75,000

Xiuling Lu, Pharmaceutical Science
Cutting Cancer at Its Root: Inhibition of Acute Leukemic Stem Cells Using Doxorubicin-Loaded Nanoparticles

Jessica Rouge, Chemistry
Determining the Pharmacology of a Novel DNAzyme-therapeutic Formulation for the Treatment of Allergic Airway Disease

 

PATH Ascent Grants – $10,000

Brian Aneskievich, Pharmaceutical Science
Establishing Protein Conformational Flexibility to Enhance Next-Step Drug-Screen Targeting

Nicholas Leadbeater, Chemistry
Towards Development of Novel Therapeutics for Treatment of Toxoplasmosis

Rajkumar Verma, Neuroscience, UConn Health
Discovery of Novel Purinergic P2X4 Receptor Antagonist for the Treatment of Ischemic Stroke

Simon White, Molecular and Cell Biology
Screening for Small Molecule Inhibitors against Enterovirus D68 2C Helicase

Ming Xu, Genetics and Genome Sciences, UConn Health
Discover Drugs Targeting Cellular Senescence to Improve Healthspan and Lifespan

For more information about PATH, visit the program website.

Thank you for helping to foster the culture of excellence in your schools/colleges, departments, and centers, that allows UConn faculty to engage in research, scholarship, and creative activities at the highest levels.

Cheers,

Radenka

OVPR Internal Funding End Date / Project Change Requests

OVPR Internal Funding End Date / Budget / Scope Change Request

This form can be used by PIs or staff who wish to request changes to an awarded OVPR internal funding project. These changes can include the end date of the project, changes in how funds are to be spent, or substantial changes in project approach or scope. The information gathered on this form will help the OVPR understand the request and its impact on the project so that an approval decision can be made. Fields marked with an asterisk (*) are required.

  • Principal Investigator Information

  • Must be a valid UConn email address.
  • Administrative Contact Information

    In case information is needed. If you are submitting this form on behalf of the PI put your contact information here.
  • Award Information

  • For Storrs Awards, please provide KFS account. For awards based at UCH, please provide Banner account number.
  • Please indicate the OVPR program under which the award was made. A full list of OVPR programs can be found here: https://ovpr.uconn.edu/services/research-development/internal-funding-opportunities/
  • When was this award originally scheduled to end? If you requested and received a revised timeline at award setup, you can reference that revised end date. If you requested and received an end date extension after the project began, do not include that extended date here.
    MM slash DD slash YYYY
  • MM slash DD slash YYYY
  • Please provide a brief summary of which project aims (as proposed in the original application) have been accomplished so far and what work remains to be completed before the project can be concluded.
  • Please provide a brief description of what delayed the project, and indicate whether those delaying elements have been resolved.
  • Will the project be able to proceed as described in the original proposal and budget? Or will there need to be changes in the plan of work and/or how the budget is spent? If so, what changes are anticipated and how do they impact the project)?
  • This field is for validation purposes and should be left unchanged.

dbGaP

  1. Request access to the controlled data sets from the appropriate dbGaP (Database of Genotypes and Phenotypes) Data Access Committee (DAC): https://dbgap.ncbi.nlm.nih.gov/aa/dbgap_request_process.pdf.
  2. Download and complete the model Data Use Certification (DUC) for the controlled data set of interest:
    • Visit the dbGAP site at http://www.ncbi.nlm.nih.gov/gap.
    • Search for the study from which data are requested. For example, “joint addiction, aging, mental health” results in number of studies.dbgap1
    • Click on the linked study title of interest for instructions on how to download the model DUC and determine if IRB approval is required. Model DUC and IRB Requirements can be found under the “Study” tab in the “Authorized Access” section (as shown in screenshot).
      dbgap2dbgap3
    • If IRB approval is required, go to the section for “dbGaP Access Request” found at https://ovpr.uchc.edu//rcs/hspp/irb/irb-instructions-forms-and-samples/
      download and complete the form “dbGaP Access Request Form for IRB Certification.”
  3. Complete the Data Security and Data Release Form (MS Word) (PDF).
  4. Email the completed Model Data Use Certification, IRB Approval for dbGaP Data Access (if required), and Data Security and Data Release Reporting form to the AVP for Research, Research IT Services – Dr. Khamis Abu-Hasaballah – at khamis@uconn.edu. Upon verification and approval of these documents, the AVP for Research will issue a certification letter signed by him, the Institutional Chief Security Officer, and the Institutional Signing Official (SPS Director).

Foreign Collaborations

INTERNATIONAL RELATIONSHIPS, FOREIGN COMPONENTS, AND SPONSORED PROGRAMS

It protects everyone’s interests – those of the Federal government, UConn, individual investigators, and their international collaborators – to have international relationships disclosed and vetted to determine if there are any potential conflict of commitments, duplications of research, and/or diversion of intellectual property in the performance of federally funded research. In some cases, failure to disclose all relationships could result in the termination of funding for a project and potential ineligibility for future funding. Noncompliance can also threaten not only the funding for individual projects, but overall funding for the University. UConn encourages international collaborations and the OVPR strongly urges investigators to err on the side of transparency in disclosing these collaborations to the University and Sponsors.

MALIGN FOREIGN TALENT RECRUITMENT PROGRAMS

Beginning 8/9/2024, all federal agencies must prohibit participation in a malign foreign talent recruitment program by covered individuals involved with research and development awards from those agencies.

UPDATE 8/7/2024: UConn has established a Malign Foreign Talent Program Participation Policy, which requires that Covered Individuals listed in a proposal for a research award from a Federal Sponsor must certify as part of the proposal submission that they are not currently participating in, nor will they participate in, a Malign Foreign Talent Recruitment Program.

Foreign Talent Recruitment Programs (Section 10631(b), Creating Helpful Incentives to Produce Semiconductors [CHIPS] and Science Act of 2022)

Section 10631(d) of the CHIPS and Science Act of 2022 requires federal research agencies to issue a policy on foreign talent recruitment programs, along with a policy specific to malign foreign talent recruitment programs. The Act prohibits “covered individuals” from participating in a federally funded research and development project if they are currently participating in a “malign foreign talent recruitment program.” Federal research agencies may request supporting documentation from applicants, and take a range of funding-related actions. The Act defines “covered individual” as “an individual who A. contributes in a substantive, meaningful way to the scientific development or execution of a research and development project proposed to be carried out with a research and development award from a Federal research agency; and B. is designated as a covered individual by the Federal research agency concerned.” (Agencies may define other individuals as covered persons as appropriate and consistent with their mission.

A malign foreign talent recruitment program is any type of program, position, or activity that involves one or more of the following:

  • Unauthorized transfer of intellectual property, materials, data or other nonpublic information;
  • Recruitment of trainees or researchers to enroll in such program, position or activity;
  • Establishing a laboratory or entity in a foreign country in violation of terms and conditions of a federal research award;
  • Accepting a faculty position, or undertaking any other employment or appointment in violation of the standard terms and conditions of a federal research award;
  • Being unable to terminate the activity except in extraordinary circumstances;
  • Being limited in capacity to carry out a federal research award;
  • Requirement to engage in work that overlaps or duplicates a federal research award;
  • Requirement to obtain research funding from the foreign government’s entities;
  • Requirement to omit acknowledgement of the U.S. home institution and/or the federal funding agency;
  • Requirement to not disclose participation in the program, position, or activity; OR
  • Having a conflict of interest or commitment contrary to a federal research award.

AND is sponsored by one of the following:

  • A foreign country of concern (currently defined as the People’s Republic of China including Hong Kong and Macau, the Democratic People’s Republic of Korea, the Russian Federation, the Islamic Republic of Iran, or any other country determined to be a country of concern by the Secretary of State); or
  • An entity based in a foreign country of concern; or
  • An institution or program on certain prohibited lists (contact the Director of Research Integrity and Security for screening).

AGENCY-SPECIFIC GUIDANCE

National Science Foundation

Individuals who are a current party to a Malign Foreign Talent Recruitment Program are not eligible to serve as a senior/key person on an NSF proposal or on any NSF award made after May 20, 2024. As of the effective date of May 20, 2024 of NSF 24-1 Proposal and Award Policies and Procedures Guide (PAPPG), the Authorized Organizational Representative (typically the Pre-Award Senior Grants and Contracts Specialist) must certify that all individuals identified as senior/key personnel have been made aware of and have complie3d with their responsibility to certify that the individual is not a party to a malign foreign talent recruitment program. IN ADDITION, each identified senior/key person must certify, in signing their Biographical Sketch form via SciENcv (required), that they are not a party to a malign foreign talent recruitment program and annually thereafter for the duration of the award.

Misrepresentations and/or omissions may be subject to prosecution and liability pursuant to, but not limited to, 18 U.S.C. §§ 287, 1001, 1031 and 31 U.S.C. §§ 3729-3733 and 3802.

National Institutes of Health

Full transparency in NIH applications and throughout the life of an NIH grant is critical. NIH requires the disclosure of all sources of research support, foreign components, and financial conflicts of interest for senior/key personnel on research applications and awards. NIH uses this information when making its funding decisions to determine if the research being proposed is receiving other sources of funding that could be duplicative, has the necessary time allocation, or if financial interests may affect objectivity in the conduct of the research.

NIH Requirements for Disclosure of Other Support, Foreign Components and Conflicts of Interest

Reminders of NIH Policies on Other Support and on Policies related to Financial Conflicts of Interest and Foreign Components (NOT-OD-19-114)

Department of Defense

Beginning August 9, 2024, the Department of Defense is prohibited from providing funding to or making an award of a fundamental research project proposal in which a covered individual is participating in a malign foreign talent recruitment program or to a proposing institution that does not have a policy addressing malign foreign talent programs pursuant to Section 10632 of the CHIPS and Science Act of 2022. 

On March 20, 2019, DoD issued a memo directing that all new DoD Notices of Funding Opportunities pertaining to research and research-related educational activities include a requirement that proposers provide additional information on the other support and commitments of all key personnel, regardless of whether the proposal is funded.

Countering Unwanted Foreign Influence in Department-Funded Research at Institutions of Higher Education

Department of Energy

DOE Order No. O 486-1: Department of Energy Foreign Government Sponsored or Affiliated Activities prohibits DOE employees and contractors participating in foreign talent recruitment programs from certain countries from receiving DOE funding. Universities must therefore disclose whether a researcher currently involved in a DOE award has participated in either a funded or unfunded Foreign Government Talent Recruitment Program.

Additional Resources

White House Office of Science and Technology Policy Foreign Talent Recruitment Program Guidelines

Recommended Practices for Strengthening the Security and Integrity of America’s Science and Technology Research Enterprise (National Science & Technology Council)


GOVERNMENT CONCERN

  1. The National Institutes of Health (NIH) issued a Notice on March 30, 2018, reminding research institutions that PIs, sub-awardees and co-PIs must disclose all financial interests received from higher education or governmental institutions in countries outside the United States (NOT-OD-18-160). NIH Director Dr. Francis S. Collins also sent a memo.pdf to institutions on Aug. 20, 2018, stating that the failure to properly disclose foreign relationships threatened to distort decision-making about the use of NIH funds.
  2. The Department of Defense
    • The National Defense Authorization Act, signed in August 2018, included Sec. 1286, which stated that “The Secretary of Defense shall, in consultation with other appropriate government organizations, establish an initiative to work with academic institutions who perform defense research and engineering activities . . . to limit undue influence, including through foreign talent programs, by countries to exploit United State Technology … ”
    • Memorandum from the Office of the Under Secretary of Defense dated October 10, 2019 which states that “the challenge of protecting the integrity of our research enterprise is a national priority.”  The letter lays out DoD’s steps to date to “limit undue influence by countries that desire to exploit DoD research, science and technology, and innovation enterprise through foreign talent programs and other means” and steps DoD plans to pursue, and calls for a dynamic, Government wide, partnership, “ No laboratory, university, industry partner, or Government agency can address the full scope of this challenge alone, and solutions to this problem can only result from a dynamic partnership between our public and private sectors.”
    • Memorandum titled “Actions for the Protection of Intellectual Property, Controlled Information, Key Personnel and Critical Technologies” dated March 20, 2019.  Directing for all new DoD Notices of Funding Opportunities related to research and research-related educational activities include requirements that “proposer submit additional Current and Active support information for all key personnel, whether or not the individuals are to funded by the DoD.
  3. The National Science Board issued a statement on “Security and Science” dated October 23, 2018, stating that US universities must “embrace transparency and rigorously adhere to conflict of interest and conflict of commitment policies.”
  4. The National Science Foundation, issued a letter on July 11 from the NSF Director to colleagues on “Research Protection” related to other support, financial conflicts of interest and foreign components (NSF 19-200).
  5. The Department of Energy issued a notification on February 1, 2019, stating that DOE plans to implement a policy, which will mandate that “federal and contractor personnel fully disclose and, as necessary, terminate affiliations with foreign government-supported talent recruitment programs.”
  6. As a reminder, NASA has long-standing restrictions on using NASA funds to enter into agreements “to participate, collaborate, or coordinate bilaterally in any way with China or any Chinese-owned company, at the prime recipient level or at any subrecipient level, whether the bilateral involvement is funded or performed under a no-exchange of funds arrangement” (grant restrictions, contract restrictions.pdf).

Foreign Components

Foreign components of federally funded research should be disclosed in proposals, progress reports, and final technical reports. Under the NIH Grants Policy Statement, a Foreign Component is defined as “any significant scientific element or segment of a project outside of the United States, either by the recipient or by a researcher employed by a foreign organization, whether or not grant funds are expended”. The definition of “foreign component” (which can be found here) may include a large number of collaborative activities, including “collaborations with investigators at a foreign site anticipated to result in co-authorship; use of facilities or instrumentation at a foreign site; or receipt of financial support or resources from a foreign entity.” Other sponsors have similar requirements to disclose foreign components.

NIH Policy on Foreign Component 

NIH requires recipients to determine whether activities it supports include a foreign component, defined as the existence of any “significant scientific element or segment of a project” outside of the United States, in other words:

1. performance of work by a researcher or recipient in a foreign location, whether or not NIH grant funds are expended and/or
2. performance of work by a researcher in a foreign location employed or paid for by a foreign organization, whether or not NIH grant funds are expended.

  • If a recipient determines that a portion of the project will be conducted outside of the U.S., the recipient then will need to determine if the activities are considered significant. If both criteria are met, then there is a foreign component.  See NIH FAQs on Other Support and Foreign Components. The addition of a foreign component to an ongoing NIH grant continues to require NIH prior approval, as outlined in the NIHGPS (Section 8.1.2) Prior Approval Requirements.
  • If an activity does not meet the definition of foreign component because all research is being conducted within the United States, but there is a non-U.S. resource that supports the research of an investigator and/or researcher, it must be reported as other support.
    For example, if a PD/PI of an NIH-funded grant has a collaborator outside of the U.S. who performs experiments in support of the PD/PI’s NIH-funded project, this would constitute a foreign component, regardless of whether the foreign collaborator receives funding from the PD/PI’s grant. Additional funding from a foreign source for the NIH-supported research of a PD/PI at a U.S. institution would not constitute a foreign component but would necessitate reporting as other support.
  • Foreign Other support must be disclosed to the NIH in advance by including it in the Just-in-Time Other Support submission on a new or renewal award, or updated in the annual RPPR, or submitted by letter to the awarding office and thereafter included in the RPPR.
  • Foreign Components applies to NIH work scope performed in a foreign location, either funded by the NIH grant or by other sources, domestic or foreign.

Also see NIH’s “Protecting U.S. Biomedical Intellectual Innovation.


Foreign Payments

The University’s Consulting Policy  requires prior approval of any remuneration, compensation, honorarium, stipends, non-university salary, or other similar payments for providing consulting, advice, services, support or other similar activities from any source, including foreign entities or persons.  The University’s Financial Conflicts of Interest in Research Policy requires disclosure of remuneration, compensation, honorarium, stipends, non-university salary, or other similar payments totaling over $5,000 in a 12 month period from a single entity, and any paid or reimbursed travel totaling over $5000 in a 12 month period by a single entity.  This include any foreign entity (e.g. governments and institutions) or persons.


Current and Other Support 

“Other Support” includes all financial resources, domestic or foreign, available in direct support of a researcher’s research endeavors.  Such support should be disclosed on an “Other Support” or “Current & Pending” form.   See here for guidance.


Past Communication

December 2020 Email from President Katsouleas: “Reminder: Threats to Research”

December 2019 Updates

How to Get Assistance?

Faculty and investigators who have questions or concerns about disclosure requirements should contact the OVPR for guidance and assistance.

Contact the OVPR

OVPR Quarterly Reports – FY19Q2

Dear Colleagues,

Now that data have been finalized, I would like to provide you with several reports relating to sponsored program activity—both research and education/service—managed by Sponsored Program Services within the Office of the Vice President for Research at UConn and UConn Health. Please visit the OVPR website to view the following reports: https://ovpr.uconn.edu/news/quarterly-reports/

  • List of Proposals Submitted: FY19 2nd Quarter
  • List of Awards Received: FY19 2nd Quarter
  • Proposals, Awards, Expenditures: FY14-FY19Q2

In the reports, data are presented in two ways: by the PI’s Academic Home Department and by the Managing Department or Center/Institute. Please refer to the first pages of the reports for definitions and information regarding the data. Should you have any questions regarding these quarterly reports, please do not hesitate to contact me.

Please note that we have included an additional Summary of Sponsored Program Activity, which includes the Effective F&A rate on awards. This information provides a snapshot of our activity as compared to the same period last year.

The OVPR continues to seek creative solutions that allow UConn and UConn Health to grow our research enterprise through federal funding, industry partnerships, and collaboration with foundations. I am confident we can continue upward trends by continuing to work together, aggressively applying for extramural funding, and pursuing new channels of support for the tremendous research, scholarship, and creative activities taking place every day at UConn and UConn Health.

Thank you for your continued commitment and contribution to our students, to your research and scholarship, and to UConn/UConn Health.

Sincerely,
Radenka

 

Dr. Radenka Maric
Vice President for Research
UConn/UCH

2019 CARIC Award Recipients Announced

Dear Colleagues,

I am pleased to announce that two teams have been selected for funding in the inaugural cycle of CARIC (Convergence Awards for Research in Interdisciplinary Centers).

CARIC supports the development of collaborative, interdisciplinary teams bidding for major federally funded research initiatives. These initiatives can include large, multi-million-dollar research grants or even entire research centers.

2019 CARIC Awards:

  • David Rowe, Director of the Center for Regenerative Medicine and Skeletal Development
    Bed to Bench (BTB) Collaboration for Skeletal Research
  • Yu Lei, Castleman Distinguished Professor, Chemical and Biomolecular Engineering
    Exposure, Health Effects, Sensing and Remediation of Emerging Contaminants Superfund Research Program (SRP) Center

The CARIC program will provide these projects with funding of up to $150,000 to support planning, outreach to strategic partners and proof-of-concept research for a year, with the possibility for renewal. This initial funding allows researchers to develop more competitive bids for prestigious national awards.

To learn more about CARIC, visit the website of the Office of the Vice President for Research.

Sincerely,

Dr. Radenka Maric
Vice President for Research
UConn/UConn Health